Tata 1mg Technologies Pvt. Ltd, which runs online pharmacy 1mg, has raised USD40 million in a funding round led by its majority shareholder Tata Digital Limited at a unicorn valuation. 

The country now has 107 unicorns, with 1mg joining a growing unicorn list of health-tech startups like PharmEasy, Innovaccer, Curefit, and Pristyn Care. Tata Digital acquired 1mg in June last year at a valuation of nearly USD450 million. In the fresh round, Tata Digital invested around USD32 million for 24,711 equity shares in 1mg, along with other investors like KWE Beteiligungen AG and HBM Healthcare Investments.

Currently, 1mg claims to deliver 31 million orders a month across 20,000 pin codes in the country. Startup news portal Entrackr was first to report the funding development in 1mg. The investment comes on the heels of the launch of Tata Neu, the flagship super app launched by Tata Digital which aims to bring the Company's data-driven omni channel experience to consumers across multiple channels.

Tata Neu is a digital gateway for consumers to discover multiple products and services offered by the Tatas. However, Tata Neu faces two challenges in bringing customers on to the Neu platform, according to brokerage house JM Financial Institutional Securities. One, the categories on Neu are neither adjacent nor allen compassing. It, therefore, will not be an automatic choice for customers looking for a one-stop shop. Two, inventory in categories such as hotels, flights, and food is limited to Tata's own brands and will, therefore, limit the customer's choice and price discovery.

'India will become $30 trillion economy..,' Piyush Goyal's big announcement

Centre releases revenue deficit grant installment to 14 states

India will have to reset and readjust to new realities: FM Sitharaman